Tariq Hassan, Anjum Saba, Din Hafeez Ud, Akhtar Farhan
Dr. Hassan Tariq, MBBS. Department of Histopathology, Armed Forces Institute of Pathology, PNS Shifa, Rawalpindi, Pakistan.
Dr. Saba Farrukh, MBBS. Department of Histopathology, Armed Forces Institute of Pathology, PNS Shifa, Rawalpindi, Pakistan.
Pak J Med Sci. 2017 Nov-Dec;33(6):1376-1380. doi: 10.12669/pjms.336.13373.
BACKGROUND & OBJECTIVE: To evaluate usefulness of immunohistochemical marker C-kit (CD117) in differentiating Adenoid cystic carcinoma (AdCC) from Polymorphous low-grade adenocarcinoma (PLGA) in patients of salivary gland carcinomas. AdCC is a malignant salivary gland neoplasm with poor prognosis. PLGA is a salivary gland malignancy with indolent growth pattern. Differentiating between the two entities is a diagnostic challenge. We evaluated the role of C-kit in differentiating the two.
This is a Cross sectional study. Samples of 19 tumors including 12 AdCC and 4 PLGA was evaluated at Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi from December 2015 to August 2016. Immunohistochemical techniques were used to analyze the level of c-kit expression in AdCC (n = 12), polymorphous low-grade adenocarcinoma (PLGA) (n = 6). Samples were stained using monoclonal antibody against C-kit. Statistical analysis of the data was done using SPSS version 21.
Strong diffuse cytoplasmic reactivity was observed in more than 50% of the tumor cells of AdCC whereas less than 20% of cells showed negative to weak positivity in PLGA. Hence, the difference in the expression of c-kit between AdCC and PLGA was statistically significant (p value <0.002).
CD117 expression itself can be used as a marker in differential diagnosis of salivary gland neoplasms. However, the percentage of the CD117 immunoreactive cells and the staining intensities appeared to be important factors in distinguishing AdCC from PLGA.
评估免疫组化标志物C-kit(CD117)在鉴别涎腺癌患者的腺样囊性癌(AdCC)与多形性低度恶性腺癌(PLGA)中的作用。腺样囊性癌是一种预后较差的涎腺恶性肿瘤。多形性低度恶性腺癌是一种生长方式相对惰性的涎腺恶性肿瘤。区分这两种实体是一项诊断挑战。我们评估了C-kit在鉴别这两者中的作用。
这是一项横断面研究。2015年12月至2016年8月期间,在拉瓦尔品第武装部队病理研究所组织病理学部门对19个肿瘤样本进行了评估,其中包括12个腺样囊性癌和4个多形性低度恶性腺癌。采用免疫组化技术分析腺样囊性癌(n = 12)、多形性低度恶性腺癌(PLGA)(n = 6)中c-kit的表达水平。样本用抗C-kit单克隆抗体染色。使用SPSS 21版对数据进行统计分析。
在超过50%的腺样囊性癌肿瘤细胞中观察到强弥漫性细胞质反应,而在多形性低度恶性腺癌中,不到20%的细胞呈阴性至弱阳性。因此,腺样囊性癌和多形性低度恶性腺癌之间c-kit表达的差异具有统计学意义(p值<0.002)。
CD117表达本身可作为涎腺肿瘤鉴别诊断的标志物。然而,CD117免疫反应性细胞的百分比和染色强度似乎是区分腺样囊性癌与多形性低度恶性腺癌的重要因素。